Finally, in 1995, Taniguchi et al. showed that the loss of IGF2 imprinting in Wilms’ tumors was associated with hypermethylation at the H19/IGF2:IG-DMR, as reported in patients with BWS [141]. The gene discussed is H19; the disease is Wilms tumor.